IOBT
IO Biotech·NASDAQ
--
--(--)
--
--(--)
3.81 / 10
Netural
Analyst sentiment is neutral, with one report labeling the stock 'Neutral' and no historical wins (0.0% win rate). Money flow, however, is positive with a 7.62/10 score; block, small, medium, large, and extra-large inflows all trend positively, hinting at institutional accumulation despite the recent sell-off. This divergence between neutral analyst views and robust fund inflows adds complexity to the near-term outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-26
InstitutionPiper Sandler
Times predicted2
Historical Win Rate0.0%
What is the market sentiment for IOBT?
- IOBT holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.81/10 (Netural).
